{"title":"Infliximab","summary":"Infliximab, a chimeric monoclonal antibody, sold under the brand name Remicade among others, is a medication used to treat a number of autoimmune diseases. This includes Crohn's disease, ulcerative colitis, rheumatoid arthritis, ankylosing spondylitis, psoriasis, psoriatic arthritis, and Beh√ßet's disease.[2] It is given by slow injection into a vein, typically at six- to eight-week intervals.[2]","image":"Infliximab_structure2.jpg.webp"}